Related Experiment Videos
[Acute hepatic porphyria and Diprivan]
1Service d'Anesthésie et Réanimation Chirurgicale, Hôpital G. et R. Laennec, Nantes.
Annales Francaises D'Anesthesie Et De Reanimation
|January 1, 1994
Summary
Propofol is safe for asymptomatic hepatic porphyria patients undergoing anesthesia. Symptomatic patients require alternative anesthesia or readily available hematin treatment, with careful monitoring and reporting of adverse events.
Area of Science:
- Anesthesiology
- Metabolic Disorders
- Pharmacology
Background:
- Hepatic porphyrias are a group of rare genetic disorders affecting heme synthesis.
- Propofol is a widely used anesthetic agent, but its safety in porphyria requires careful consideration.
Purpose of the Study:
- To provide guidance on the safe use of propofol in patients with hepatic porphyrias.
- To outline alternative anesthetic strategies and necessary precautions.
Main Methods:
- Review of existing literature and clinical guidelines regarding propofol use in porphyria.
- Analysis of potential risks and benefits of propofol in different porphyria subtypes.
Main Results:
- Propofol can be safely administered to patients with asymptomatic hepatic porphyria.
- For symptomatic hepatic porphyria, alternative anesthetics like neuroleptanalgesia, benzodiazepines, and muscle relaxants are preferred.
- If propofol is used in symptomatic cases, hematin treatment must be available, and porphyrin levels monitored.
Conclusions:
- Careful patient selection and monitoring are crucial when using propofol in hepatic porphyria.
- Adherence to specific protocols, including notification of porphyria centers, is essential for patient safety.